An announcement from Auna S.A. Class A ( (AUNA) ) is now available.
On April 10, 2025, Auna S.A. announced the filing of its Annual Report on Form 20-F for the fiscal year ending December 31, 2024, with the SEC. This filing provides stakeholders with access to the company’s audited financial statements and reflects Auna’s commitment to transparency and regulatory compliance, potentially impacting its market positioning and investor confidence.
Spark’s Take on AUNA Stock
According to Spark, TipRanks’ AI Analyst, AUNA is a Neutral.
Auna S.A.’s stock demonstrates strong financial performance through robust revenue growth and improved profitability, though its high leverage remains a concern. The technical analysis indicates a bearish trend due to the stock trading below key moving averages. The valuation is reasonable, reflecting fair market pricing. The absence of earnings call and corporate events data leaves some uncertainty regarding near-term catalysts.
To see Spark’s full report on AUNA stock, click here.
More about Auna S.A. Class A
Auna S.A. is a leading healthcare company in Latin America, operating in Mexico, Peru, and Colombia. It focuses on high-complexity diseases and aims to transform healthcare by providing access to integrated healthcare services in underpenetrated markets. Founded in 1989, Auna has developed a large healthcare platform with 31 facilities, including hospitals and wellness centers, and offers 1.4 million healthcare plans.
YTD Price Performance: -6.16%
Average Trading Volume: 43,372
Technical Sentiment Signal: Strong Buy
Current Market Cap: $204.6M
For an in-depth examination of AUNA stock, go to TipRanks’ Stock Analysis page.